With the formation of a new strategic partnership, Dyno Therapeutics is responsible for the development of novel AAV capsids.

Dyno Therapeutics has recently announced the formation of a new strategic partnership with Swiss pharma giant Roche to ...

In this case report, Gad and colleagues performed corneal confocal microscopy to assess for evidence of nerve regeneration ...

Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect profile that is consistent with high-dose steroid use in other conditions ...

Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on Taysha Gene Therapies (TSHA – Research Report) yesterday and set a ...

may prove to be more amenable to genetic analysis". Monogenic causes of IS Monogenic disorders related with IS are uncommon, accounting for approximately 1% of all strokes. Examples are some ...

A Queen’s internal medicine resident is paving the way for a brighter future in kidney health. Dr. Caitlyn Vlasschaert has been named the first STAT Wunderkind researcher from Queen’s—a major ...

Liddle syndrome is an autosomal dominant disorder caused by hyperactivity ... The authors declared no competing interests. Monogenic hypertension is caused by single gene mutations and accounts ...

Then it'll be used for common monogenic disease, then polygenic disease or diseases where there's a genetic component. And ultimately we will be able to add genetic influences to diseases that don ...

In a report released today, Joseph Stringer from Needham maintained a Buy rating on Avidity Biosciences (RNA – Research Report), with a ...

Zurich continues to push boundaries in Healthcare and InsureTech with the Zurich Innovation Championship (ZIC) by working ...